文献速递免疫规划传染病防控与疫情报告

MMR疫苗第三剂后腮腺炎免疫的性别差异

Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine.
PubMed 文献 · Vaccine · 2026-03-20

研究对214名既往接种两剂MMR的健康个体接种第三剂MMR,随访18个月。结果显示IgG、亲和力和中和抗体均显著上升但增幅有限,且免疫应答受性别显著影响,IP-10与IgG变化负相关。结论支持MMR3主要用于疫情暴发控制。

要点

  • MMR3仅带来有限的额外体液和细胞免疫获益,抗体增幅小。
  • 性别显著影响IgG和IP-10应答,需关注性别差异。
  • IP-10或可作为MMR3免疫原性的潜在生物标志物。

核心结论

  • MMR3对腮腺炎免疫的额外获益有限,且存在性别依赖效应。
  • 研究支持MMR3主要用于腮腺炎暴发控制。
  • IP-10是与MMR3免疫原性相关的潜在生物标志物。

研究设计与样本

  • 214名既往接种两剂MMR的健康个体接种MMR3。
  • 在基线(D0)、接种后28天(D28)和18个月(M18)采集血样。
  • 检测腮腺炎特异性IgG、IgG亲和力和中和抗体,并分析PBMC分泌的细胞因子和趋化因子。

主要发现

  • IgG中位样本指数从D0的2.12升至D28的2.64(p=0.0019)和M18的2.85(p<0.001)。
  • IgG亲和力从D0的79.54%略升至D28的81.88%和M18的86.87%。
  • 中和抗体滴度(ND50)从D0的50.48升至D28的67.00(p=0.0014)和M18的60.18(p=0.044)。
  • 各时间点倍数增加较小:IgG为1.15-1.13,亲和力为1.03-1.08,中和抗体为1.2-1.18。
  • 21种细胞因子/趋化因子中仅IP-10显著升高,且与D28/D0的IgG变化负相关(r=-0.23;p=0.014)。

临床怎么用

  • MMR3应主要考虑用于腮腺炎暴发控制,而非普遍加强免疫。
  • 评估MMR3免疫效果时需考虑性别差异。
  • IP-10可作为监测MMR3免疫原性的候选生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A third dose of measles-mumps-rubella (MMR3) vaccine is recommended for mumps outbreak control, but the magnitude and durability of MMR3-induced immunity and the effect of sex on those outcomes, remain incompletely characterized. METHODS: A total of 214 healthy individuals with two prior MMR doses received MMR3. Blood samples were collected at baseline (D0), day 28 (D28), and 18 months (M18) post-vaccination. Mumps-specific IgG, IgG avidity, and neutralizing antibodies (nAb) were measured by IgG ELISA and plaque reduction microneutralization assay. Cytokine and chemokine secretions from peripheral blood mononuclear cells (PBMCs) were profiled using multiplex assay. RESULTS: Median IgG sample index values increased from 2.12 at D0 to 2.64 at D28 (p = 0.0019), and 2.85 at M18 (p < 0.001). IgG avidity rose slightly from 79.54% at D0 to 81.88% at D28 and 86.87% at M18. nAb titers (ND50) increased from 50.48 at D0 to 67.00 at D28 (p = 0.0014), and 60.18 at M18 (p = 0.044). Despite these statistically significant changes, fold increases across time points were small (IgG: 1.15-1.13; avidity: 1.03-1.08; and nAb: 1.2-1.18). Of the 21 cytokines and chemokines analyzed, only interferon-γ induced protein 10 (IP-10/CXCL10) showed significant increase and was negatively correlated with D28/D0 changes in IgG titers (r = -0.23; p = 0.014), but not with M18 changes, avidity, or nAb responses. Biological sex significantly influenced both IgG and IP-10 responses. CONCLUSIONS: MMR3 conferred limited additional humoral and cellular immune benefits, with notable sex-dependent effects. These findings support MMR3 use primarily in outbreak settings and identify IP-10 as a potential biomarker associated with MMR3 immunogenicity.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Quach HQ, Ratishvili T, Haralambieva IH, et al. Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine. Vaccine. 2026. PMID: 41863912. doi:10.1016/j.vaccine.2026.128480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。